Rapid-Myco Technologies

Curated by Signal

Developer of a diagnostic platform for the detection of mycobacterial infections in humans and livestock

Overview

Developer of a diagnostic platform for the detection of mycobacterial infections in humans and livestock. It offers bacteriophage (phage)-based qPCR test based on RAPIDvMAP technology for apid detection of Mycobacterium, bovine TB, and zoonotic bovine TB.

Key facts

Founded: 2021
Headquarters: Belfast, United Kingdom
Stage: Sign up to view
Industry: Health Technology

Business model

2 products and services: Sign up to view

Contact

Primary office: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Techmedology
Provider of smart devices & mobile app for chronic disease management in elders
Health TechnologyLondon, United Kingdom
ChestPal
AI-powered digital stethoscope to assist frontline healthcare providers
Health TechnologyBrighton, United Kingdom
Shire Dental System
Dental practice management tool for healthcare professionals
Health TechnologyNorthwich, United Kingdom

About Rapid-Myco Technologies

What does Rapid-Myco Technologies do?

Developer of a diagnostic platform for the detection of mycobacterial infections in humans and livestock.

Where is Rapid-Myco Technologies headquartered?

Rapid-Myco Technologies is headquartered in Belfast, United Kingdom.

When was Rapid-Myco Technologies founded?

Rapid-Myco Technologies was founded in 2021.

Which sector is Rapid-Myco Technologies in?

Rapid-Myco Technologies operates in Health Technology.

Who are Rapid-Myco Technologies's competitors?

Companies similar to Rapid-Myco Technologies include Techmedology, ChestPal, and Shire Dental System.